License AgreementLicense Agreement • March 3rd, 2022 • Atreca, Inc. • Pharmaceutical preparations • Delaware
This License Agreement (this “Agreement”) is entered into as of the date of last signature (the “Effective Date”) by the Bill & Melinda Gates Medical Research Institute, a nonprofit research institution organized under the laws of the state of Washington with its principal offices located at One Kendall Square, Building 600, Suite 6-301, Cambridge, MA 02139 (the “Gates MRI”), and Atreca, Inc., a corporation organized under the laws of Delaware with its principal offices located at 835 Industrial Road, Suite 400, San Carlos, CA 94070 (“Atreca”). The Gates MRI and Atreca are also collectively referred to herein as the “Parties” or individually as a “Party.”
CERTAIN INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDMENT NO. 2 TO EXCLUSIVE (EQUITY) AGREEMENTEquity) Agreement • March 3rd, 2022 • Atreca, Inc. • Pharmaceutical preparations • California
This AMENDMENT NO. 2 TO EXCLUSIVE (EQUITY) AGREEMENT (“Amendment”) is effective as of July 2, 2020 (“Amendment Effective Date”), by and between The Board of Trustees of the Leland Stanford Junior University, an institution of higher education having powers under the laws of the State of California (“Stanford”), and Atreca, Inc., a Delaware corporation having an address at 450 East Jamie Court, South San Francisco, CA 94080 (“Atreca”). Each of Stanford and Atreca are referred to in this Amendment as a “Party” and together, the “Parties.”
